Your session is about to expire
← Back to Search
WellQuest™ for Diabetes
N/A
Waitlist Available
Led By Kevin Jarvis, PharmD
Research Sponsored by BioCentric, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
This trial will test whether adding the game to the National DPP lifestyle change program will help people with prediabetes adopt healthier habits and stick with the program.
Eligible Conditions
- Diabetes
- Diabetes Mellitus
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ six months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~six months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of Sessions Attended
Secondary outcome measures
Daily time spent playing the serious health game in participants who downloaded the game.
Game downloads among participants randomized to the experimental arm
Participants' game rating/Net Promoter Score or questionnaire.
+1 moreOther outcome measures
Body weight (and/or body mass index [BMI]) change over time
Comparability of health data collected by the game and data reported by the organization
Completeness of health data collected by the game
+6 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental Arm - WellQuest™ UsersExperimental Treatment1 Intervention
Participants in National DPP groups randomized to the experimental arm will be instructed by lifestyle coaches to download the WellQuest™ game application and will receive instructions on how to use the game throughout the LCP.
Group II: Control ArmActive Control1 Intervention
Participants in National DPP groups randomized to the control arm will proceed with their routine National DPP participation.
Find a Location
Who is running the clinical trial?
Centers for Disease Control and PreventionFED
875 Previous Clinical Trials
22,476,852 Total Patients Enrolled
3 Trials studying Diabetes
17,225 Patients Enrolled for Diabetes
BioCentric, Inc.Lead Sponsor
Kevin Jarvis, PharmDPrincipal InvestigatorBioCentric, Inc.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What state do they live in?
New Jersey
How old are they?
18 - 65
What site did they apply to?
BioCentric, Inc.
What portion of applicants met pre-screening criteria?
Met criteria
Share this study with friends
Copy Link
Messenger